1. Home
  2. TPST vs WVVI Comparison

TPST vs WVVI Comparison

Compare TPST & WVVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPST
  • WVVI
  • Stock Information
  • Founded
  • TPST 2011
  • WVVI 1983
  • Country
  • TPST United States
  • WVVI United States
  • Employees
  • TPST N/A
  • WVVI N/A
  • Industry
  • TPST Biotechnology: Pharmaceutical Preparations
  • WVVI Beverages (Production/Distribution)
  • Sector
  • TPST Health Care
  • WVVI Consumer Staples
  • Exchange
  • TPST Nasdaq
  • WVVI Nasdaq
  • Market Cap
  • TPST 33.0M
  • WVVI 28.2M
  • IPO Year
  • TPST N/A
  • WVVI N/A
  • Fundamental
  • Price
  • TPST $7.54
  • WVVI $4.85
  • Analyst Decision
  • TPST Hold
  • WVVI
  • Analyst Count
  • TPST 3
  • WVVI 0
  • Target Price
  • TPST $30.00
  • WVVI N/A
  • AVG Volume (30 Days)
  • TPST 94.0K
  • WVVI 6.3K
  • Earning Date
  • TPST 08-11-2025
  • WVVI 08-12-2025
  • Dividend Yield
  • TPST N/A
  • WVVI N/A
  • EPS Growth
  • TPST N/A
  • WVVI N/A
  • EPS
  • TPST N/A
  • WVVI N/A
  • Revenue
  • TPST N/A
  • WVVI $38,520,945.00
  • Revenue This Year
  • TPST N/A
  • WVVI N/A
  • Revenue Next Year
  • TPST N/A
  • WVVI N/A
  • P/E Ratio
  • TPST N/A
  • WVVI N/A
  • Revenue Growth
  • TPST N/A
  • WVVI N/A
  • 52 Week Low
  • TPST $5.35
  • WVVI $3.17
  • 52 Week High
  • TPST $28.34
  • WVVI $7.18
  • Technical
  • Relative Strength Index (RSI)
  • TPST 56.78
  • WVVI 37.97
  • Support Level
  • TPST $7.13
  • WVVI $4.78
  • Resistance Level
  • TPST $8.75
  • WVVI $4.95
  • Average True Range (ATR)
  • TPST 0.47
  • WVVI 0.17
  • MACD
  • TPST 0.12
  • WVVI -0.00
  • Stochastic Oscillator
  • TPST 54.17
  • WVVI 22.16

About TPST Tempest Therapeutics Inc.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

About WVVI Willamette Valley Vineyards Inc.

Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.

Share on Social Networks: